Atlas Trials

A Study of Oxaliplatin and Capecitabine in Unresectable Metastatic Hepatocellular Cancer

Clinical trial NCT03026803 · TERMINATED

Trial details

NCT number
NCT03026803
Sponsor
City of Hope Medical Center
Status
TERMINATED
Phase
Phase 2
Study type
INTERVENTIONAL
Liver CancerHepatocellular Cancer
Start date
2006-11-01
Primary completion
2014-10-01
Enrollment
4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.